{"id":"https://openalex.org/W2317536368","doi":"https://doi.org/10.1097/coc.0b013e3181e84634","title":"Impact of Epidermal Growth Factor Receptor Expression on Disease-Free Survival and Rate of Pelvic Relapse in Patients With Advanced Cancer of the Cervix Treated With Chemoradiotherapy","display_name":"Impact of Epidermal Growth Factor Receptor Expression on Disease-Free Survival and Rate of Pelvic Relapse in Patients With Advanced Cancer of the Cervix Treated With Chemoradiotherapy","publication_year":2010,"publication_date":"2010-09-21","ids":{"openalex":"https://openalex.org/W2317536368","doi":"https://doi.org/10.1097/coc.0b013e3181e84634","mag":"2317536368","pmid":"https://pubmed.ncbi.nlm.nih.gov/20859196"},"language":"en","primary_location":{"id":"doi:10.1097/coc.0b013e3181e84634","doi":"https://doi.org/10.1097/coc.0b013e3181e84634","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coc.0b013e3181e84634","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032022819","display_name":"Jose Fermin P\u00e9rez-Regadera","orcid":"https://orcid.org/0000-0003-3525-3967","observed_orcids":["https://orcid.org/0000-0003-3525-3967"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Jos\u00e9 P\u00e9rez-Regadera","raw_affiliation_strings":["Department of Radiation Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain. asmoncomed@yahoo.es","Department of Radiation Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain. asmoncomed@yahoo.es","institution_ids":["https://openalex.org/I4210101691"]},{"raw_affiliation_string":"Department of Radiation Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112455495","display_name":"Alfonso S\u00e1nchez\u2010Mu\u00f1oz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210157481","display_name":"Hospital Cl\u00ednico Universitario Virgen de la Victoria","ror":"https://ror.org/05xxs2z38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210157481"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alfonso S\u00e1nchez-Mu\u00f1oz","raw_affiliation_strings":["Department of Medical Oncology, Hospital Universitario Virgen de la Victoria de M\u00e1laga, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Universitario Virgen de la Victoria de M\u00e1laga, Spain","institution_ids":["https://openalex.org/I4210157481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043092851","display_name":"Javier de la Cruz","orcid":"https://orcid.org/0000-0002-2010-4128","observed_orcids":["https://orcid.org/0000-0002-2010-4128"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Javier De-la-Cruz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033260748","display_name":"Claudio Ballest\u00edn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudio Ballest\u00edn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061076401","display_name":"David Lora","orcid":"https://orcid.org/0000-0002-3317-5689","observed_orcids":["https://orcid.org/0000-0002-3317-5689"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Lora","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002606241","display_name":"Rosa Garc\u00eda-Mart\u00edn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosa Garc\u00eda-Mart\u00edn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055787031","display_name":"Amalia Sotoca","orcid":"https://orcid.org/0000-0002-9760-7698","observed_orcids":["https://orcid.org/0000-0002-9760-7698"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Amalia Sotoca","raw_affiliation_strings":["Department of Radiation Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071761676","display_name":"El\u00edsabeth P\u00e9rez-Ruiz","orcid":"https://orcid.org/0000-0001-7204-0800","observed_orcids":["https://orcid.org/0000-0001-7204-0800"]},"institutions":[{"id":"https://openalex.org/I4210157481","display_name":"Hospital Cl\u00ednico Universitario Virgen de la Victoria","ror":"https://ror.org/05xxs2z38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210157481"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elisabeth P\u00e9rez-Ruiz","raw_affiliation_strings":["Department of Medical Oncology, Hospital Universitario Virgen de la Victoria de M\u00e1laga, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Universitario Virgen de la Victoria de M\u00e1laga, Spain","institution_ids":["https://openalex.org/I4210157481"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008137528","display_name":"Eduardo Lanz\u00f3s","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Eduardo Lanz\u00f3s","raw_affiliation_strings":["Department of Radiation Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5008137528","https://openalex.org/A5032022819","https://openalex.org/A5055787031"],"corresponding_institution_ids":["https://openalex.org/I4210101691"],"apc_list":null,"apc_paid":null,"fwci":1.7024,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.84225118,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"34","issue":"4","first_page":"395","last_page":"400"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.996999979019165},{"id":"https://openalex.org/keywords/egfr-overexpression","display_name":"EGFR overexpression","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cervical-cancer","display_name":"cervical cancer","score":0.8700000047683716},{"id":"https://openalex.org/keywords/advanced-cervical-cancer","display_name":"advanced cervical cancer","score":0.8349999785423279},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/concurrent-chemoradiotherapy","display_name":"concurrent chemoradiotherapy","score":0.9129999876022339},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9610000252723694},{"id":"https://openalex.org/keywords/radioresistance-biology","display_name":"radioresistance (biology)","score":0.9240000247955322},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.913094162940979},{"id":"https://openalex.org/C2778424827","wikidata":"https://www.wikidata.org/wiki/Q5090613","display_name":"Chemoradiotherapy","level":3,"score":0.6297081112861633},{"id":"https://openalex.org/C2777740455","wikidata":"https://www.wikidata.org/wiki/Q666412","display_name":"Cervix","level":3,"score":0.6193826794624329},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5741811990737915},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.5699559450149536},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5586620569229126},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5454138517379761},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5091592669487},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4631592035293579},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4390066862106323},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43449386954307556},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3388584852218628},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.27927666902542114},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001918","descriptor_name":"Brachytherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002583","descriptor_name":"Uterine Cervical Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007124","descriptor_name":"Immunoenzyme Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D010386","descriptor_name":"Pelvic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D010386","descriptor_name":"Pelvic Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D010386","descriptor_name":"Pelvic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018196","descriptor_name":"Carcinoma, Adenosquamous","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D018196","descriptor_name":"Carcinoma, Adenosquamous","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D018196","descriptor_name":"Carcinoma, Adenosquamous","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/coc.0b013e3181e84634","doi":"https://doi.org/10.1097/coc.0b013e3181e84634","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coc.0b013e3181e84634","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:20859196","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20859196","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1634108692","https://openalex.org/W1920528371","https://openalex.org/W1935824237","https://openalex.org/W1964321121","https://openalex.org/W1971653050","https://openalex.org/W1983143162","https://openalex.org/W1984363009","https://openalex.org/W1992538168","https://openalex.org/W1995821713","https://openalex.org/W1995992733","https://openalex.org/W1996475495","https://openalex.org/W2013896394","https://openalex.org/W2028561109","https://openalex.org/W2041140757","https://openalex.org/W2052856777","https://openalex.org/W2062016496","https://openalex.org/W2064047613","https://openalex.org/W2072199736","https://openalex.org/W2079879369","https://openalex.org/W2082601735","https://openalex.org/W2082700518","https://openalex.org/W2090401278","https://openalex.org/W2093620760","https://openalex.org/W2094970629","https://openalex.org/W2097945491","https://openalex.org/W2098287668","https://openalex.org/W2129944002","https://openalex.org/W2157719711","https://openalex.org/W2157838504","https://openalex.org/W2163252214","https://openalex.org/W2205154749","https://openalex.org/W2314753133","https://openalex.org/W2328935341","https://openalex.org/W2407135480","https://openalex.org/W2413917914","https://openalex.org/W2418593999","https://openalex.org/W2439513927","https://openalex.org/W4239819457","https://openalex.org/W6636470863"],"related_works":["https://openalex.org/W2266026150","https://openalex.org/W2003969184","https://openalex.org/W2040574090","https://openalex.org/W2315675977","https://openalex.org/W2604624391","https://openalex.org/W2155405231","https://openalex.org/W2077257662","https://openalex.org/W7098348985","https://openalex.org/W2494927293","https://openalex.org/W2129944002"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"determine":[2],"the":[3,6,28,42,62,127,198,203],"impact":[4,119],"of":[5,8,27,41,64,85,149,166,197,202,209,220,227],"expression":[7,63],"epidermal":[9],"growth":[10],"factor":[11],"receptor":[12],"(EGFR)":[13],"on":[14,19,120],"disease-free":[15,215],"survival":[16],"(DFS)":[17],"and":[18,59,70,74,87,105,122,138,169,200,212],"pelvic":[20,123,210],"relapse":[21,168],"in":[22,72,230],"patients":[23,37],"with":[24,38,54,78,109,114,155,162,183,195],"advanced":[25,39],"cancer":[26,40],"cervix":[29,43,199],"receiving":[30],"concurrent":[31],"chemoradiotherapy.":[32],"METHODS:":[33],"In":[34],"112":[35,128],"consecutive":[36],"(11":[44],"stage":[45],"IB2-IIA,":[46],"25":[47],"IIB,":[48],"63":[49],"IIIB,":[50],"13":[51],"IVA)":[52],"treated":[53],"chemoradiotherapy":[55],"between":[56],"December":[57],"1994":[58],"September":[60],"2004,":[61],"EGFR":[65,150],"using":[66],"histoimmunochemistry":[67],"was":[68,152],"measured":[69],"used":[71],"univariate":[73],"multivariate":[75],"analysis,":[76],"along":[77],"variables":[79],"such":[80],"as":[81],"age,":[82],"International":[83],"Federation":[84],"Gynecology":[86],"Obstetrics":[88],"Staging":[89],"System":[90],"for":[91],"Epithelial":[92],"Ovarian":[93],"Cancer":[94],"(FIGO)":[95],"stage,":[96],"histology,":[97],"Eastern":[98],"Cooperative":[99],"Oncology":[100],"Group":[101],"(ECOG),":[102],"tumor":[103],"size,":[104],"ganglia":[106],"involvement":[107],"diagnosed":[108],"computerized":[110],"axial":[111],"tomography,":[112],"treatment":[113,182],"cisplatin":[115,184],"to":[116],"evaluate":[117],"its":[118],"DFS":[121,172,186],"relapse.":[124],"RESULTS:":[125],"Of":[126],"biopsies,":[129],"32":[130],"(28.6%)":[131],"were":[132,141],"negative":[133],"or":[134,143],"slightly":[135],"positive":[136,145],"(EGFR\u00b1)":[137],"80":[139],"(71.4%)":[140],"moderate":[142],"intensely":[144],"(EGFR++/+++).":[146],"The":[147,217],"overexpression":[148,201],"(++/+++)":[151],"significantly":[153],"associated":[154],"an":[156,228],"epidermoid":[157],"histology":[158],"(P":[159],"<":[160],"0.0001),":[161],"a":[163,170,206,213,225],"higher":[164,207],"rate":[165],"pelvis":[167],"decreased":[171,214],"(hazard":[173],"ratio":[174],"[HR]:":[175],"2.31":[176],"[1.08-4.96];":[177],"P":[178,190],"=":[179,191],"0.03).":[180],"Overall,":[181],"increased":[185],"(HR:":[187],"0.51":[188],"[0.26-0.97];":[189],"0.04).":[192],"CONCLUSIONS:":[193],"Patients":[194],"tumors":[196,222],"EGFR++/+++":[204],"show":[205],"probability":[208],"relapses":[211],"survival.":[216],"poor":[218],"prognosis":[219],"these":[221],"may":[223],"be":[224],"consequence":[226],"increase":[229],"radio-resistance.":[231]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}